Arunai College of Pharmacy, Tiruvannamalai, Tamil Nadu, India
Morinda citrifolia (Noni) is a medicinal plant widely used in traditional medicine for its antimicrobial properties. The present study aimed to evaluate the antimicrobial activity of Morinda citrifolia (Flowers) extract using nutrient broth medium, disc diffusion method, agar well diffusion method, and serial dilution techniques. Phytochemical screening was performed to identify active compounds, and molecular docking studies were carried out to analyze the interaction between phytoconstituents and microbial target proteins. The extract showed significant inhibition against selected microorganisms compared to blank control. Percentage inhibition was calculated using serial dilution results. Molecular docking revealed strong binding affinity of bioactive compounds with bacterial protein targets, supporting the experimental findings. The study confirms the antimicrobial potential of Morinda citrifolia and explains its mechanism at the molecular level.
An antimicrobial is an agent that kills microorganisms (microbicide) or stops their growth (bacteriostatic agent). Antimicrobial medicines can be grouped according to the microorganisms they are used to treat.
For example, antibiotics are used against bacteria, and antifungals are used against fungi. They can also be classified according to their function.
Antimicrobial medicines to treat infection are known as antimicrobial chemotherapy, while antimicrobial drugs are used to prevent infection, which known as antimicrobial prophylaxis.
The main classes of antimicrobial agents are disinfectants (non-selective agents, such as bleach), which kill a wide range of microbes on surfaces to prevent the spread of illness, antiseptics which are applied to living tissue and help reduce infection during surgery, and antibiotics which destroy microorganisms within the body.
ANTIFUNGALS
Antifungals are used to kill or prevent further growth of fungi. In medicine, they are used as a treatment for infections such as athlete's foot, ringworm and thrush and work by exploiting differences between mammalian and fungal cells. Unlike bacteria, both fungi and humans are eukaryotes.
ANTIVIRAL
Antiviral drugs are a class of medication used specifically for treating viral infections. Like antibiotics, specific antivirals are used for specific viruses. They should be distinguished from vermicides, which actively deactivate virus particles outside the body.
ANTIPARASITIC:
Antiparasitic are a class of medications which are indicated for the treatment of parasitic diseases, such as those caused by helminthes, amoeba, ectoparasites, parasitic fungi, and protozoa, among others. Antiparasitic target the parasitic agents of the infections by destroying them or inhibiting their growth; they are usually effective against a limited number of parasites within a Particular class
MECHANISM OF ACTION OF ANTI MICROBIALS:
5. Inhibition of Essential Metabolic Pathways
PLANT PROFILE
NONI
Common name: Indian Mulberry, Great Morinda, Cheesefruit,
Scientific name: Morindia citrifolia
Family : Rubiaceae
Geographical source: Kerala, Karnataka and Tamil Nadu
Scientific classification:
Vernacular names:
English : Indian Mulberry
Tamil : Nuna
Hindi : Bartundi
Telugu : Mogali
Kannada : Tagase maddi
Description:
Morinda citrifolia is a shrub or small tree up to 6 m tall, with grey-brown bark. The twigs are more or less square in cross-section and often fleshy. Stipules are present, very broad and obtuse at the apex, measuring up to 2 cm wide and long. The large glabrous leaves are elliptic to ovate in shape and have 6–9 pairs of lateral veins. The flowers are white and tubular with five lobes, measuring about 15 cm long and across.
The fruits are initially green, transitioning through pale yellow to white or grey, and when ripe they emit a pungent odour. They are irregularly ellipsoid or ovoid.
Chemical constituent:
Morinda citrifolia fruit powder contains carbohydrates and dietary fibre in moderate amounts. These macronutrients reside in the fruit pulp, as M. citrifolia juice has sparse nutrient content. Morinda citrifolia fruit contains diverse phytochemicals, including anthraquinones, lignans, oligo- and polysaccharides, flavonoids, iridoids, such as deacetylasperulosidic acid, scopoletin , fatty acids, catechin, beta-sitosterol, damnacanthal, and alkaloids.
Pharmacological profile:
MOLECULAR DESIGN:
Molecular design is the process of finding new medicines based on the knowledge of a biological target, it enabled the chemist to predict the structure and then it also allows the medicinal chemist to evaluate the interaction between a compound and its target site before synthesizing a compound so as to increase the ability by reducing the side effects.
Various software used :
MOL INSPIRATION
This software is used to calculate the following properties
In addiction to “LIPINSKI’S RULE” another rule was proposed VEBER he states that the number of rotatable bonds should be less than 10. This rule is more appropriate for oral drug only. According to the veber’s rule .
3D STRUCTURAL VIEW OF COMPOUNDS:
|
SCOPOLETIN |
LINALOOL |
|
RUTIN |
GALLIC ACID |
|
CAFEIC ACID |
URSOLIC ACID |
|
OLEANOLIC ACID |
β-SITOSTEROL |
|
URSANE |
TANNIC ACID |
|
CATECHIN |
EPICATECHIN |
|
DEACETYL ASPERULOSIDIC ACID(DAA) |
ASPERULOSIDIC ACID(AA) |
|
TIGOGENIN |
OLEONANE |
|
QUERCETIN |
KAEMPFEROL |
Table-1: Properties of Phytoconstituents
|
Sr. No |
Phytoconstituents |
PubChem Id |
Molecular Weight |
Molecular Formula |
|
1 |
Scopoletin |
5280460 |
192.17 g/mol |
C10H8O4 |
|
2 |
Quercetine |
5280343 |
302.23 g/mol |
C15H10O7 |
|
3 |
Kaempferol |
5280863 |
286.24 g/mol |
C15H10O6 |
|
4 |
Rutin |
6728944 |
610.5 g/mol |
C27H30O16 |
|
5 |
Gallic Acid |
370 |
170.12g/mol |
C7H6O5 |
|
6 |
Caffeic Acid |
689043 |
180.16g/mol |
C9H8O4 |
|
7 |
Ursolic Acid |
64945 |
456.7g/mol |
C30H48O3 |
|
8 |
Oleanolic Acid |
10494 |
456.7g/mol |
C30H48O3 |
|
9 |
Β-SITOSTEROL |
222284 |
414.7g/mol |
C29H50O |
|
10 |
Linalool |
6549 |
154.25g/mol |
C10H18O |
|
11 |
Tannic Acid |
16129778 |
1701.2g/mol |
C76H52O46 |
|
12 |
Catechin |
9064 |
290.27g/mol |
C15H14O6 |
|
13 |
Epicatechin |
72276 |
290.27g/mol |
C15H14O6 |
|
14 |
Deacetylasperulosidic Acid (DAA) |
12315350 |
390.34g/mol |
C16H22O11 |
|
15 |
Asperulosidic Acid (AA) |
119688 |
432.4g/mol |
C18H24O12 |
|
16 |
Tigogenin |
99516 |
416.6 g/mol |
C27H44O3 |
|
17 |
Oleanane |
9548717 |
412.27 g/mol |
C56H92O29 |
|
18 |
Ursane |
9548870 |
412.7 g/mol |
C30H52 |
Table-2: ADME Properties of Phytoconstituents
|
Sr. No. |
Phytoconstituents |
Number of Rotatabe Bonds |
Number of Bond Acceptor |
Number of Bond Donor |
Lpgpc/ W9 (Liogl) |
Molar Refractive |
Solubility |
Gastro Intestinal Absorption |
|
1 |
Scopoletin |
1 |
4 |
1 |
1.86 |
51.00 |
Soluble |
High |
|
2 |
Quercetine |
1 |
7 |
5 |
1.63 |
78.03 |
Soluble |
High |
|
3 |
Kaempferol |
1 |
6 |
4 |
1.70 |
76.01 |
Soluble |
High |
|
4 |
Rutin |
6 |
16 |
10 |
0.46 |
141.38 |
Soluble |
Low |
|
5 |
Gallic Acid |
1 |
5 |
4 |
0.21 |
39.47 |
Soluble |
High |
|
6 |
Caffeic Acid |
2 |
4 |
3 |
0.97 |
47.16 |
Soluble |
High |
|
7 |
Ursolic Acid |
1 |
3 |
2 |
3.95 |
136.91 |
Moderately Soluble |
Low |
|
8 |
Oleanolic Acid |
1 |
3 |
2 |
3.94 |
136.65 |
Paartially Soluble |
Low |
|
9 |
Β-Sitosterol |
6 |
1 |
1 |
5.05 |
133.23 |
Partially .Soluble |
Low |
|
10 |
Linalool |
4 |
1 |
1 |
2.70 |
50.44 |
Soluble |
High |
|
11 |
Tannic Acid |
10 |
19 |
11 |
0.36 |
142.56 |
Soluble |
Low |
|
12 |
Catechin |
1 |
6 |
5 |
1.33 |
74.33 |
Soluble |
High |
|
13 |
Epicatechin |
1 |
6 |
5 |
1.47 |
74.33 |
Soluble |
High |
|
14 |
Deacetyl Asperulosidic Acid (DAA) |
5 |
11 |
7 |
0.58 |
83.73 |
Soluble |
Low |
|
15 |
Asperulosidic Acid (AA) |
7 |
12 |
6 |
1.13 |
93.47 |
Soluble |
Low |
|
16 |
Tigogenin |
7 |
13 |
1 |
4.53 |
122.07 |
Moderately .Soluble |
High |
|
17 |
Oleanane |
0 |
0 |
0 |
5.05 |
134.19 |
Partially .Soluble |
Low |
|
18 |
Ursane |
0 |
0 |
0 |
5.02 |
134.45 |
Partially .Soluble |
Low |
Table 3: Toxicity Study of Phytoconstituents
|
Sr. No
|
Phyto-Constituents |
Nephlo Toxicity |
Carcino-toxicity |
Cardio Toxicity |
Muta Geneciy |
Cyto Toxicity |
Bbb-Barrier |
Nutritional Toxicity
|
Aryl- Hydro-Carbon Receptor |
Andro Gen Receptr |
|
1 |
Scopoletin |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
2 |
Quercetin |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
3 |
Kaempferol |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
4 |
Rutin |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
5 |
Gallic Acid |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
6 |
Caffeic Acid |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
7 |
Ursolic Acid |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
8 |
Oleanolic Acid |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
9 |
Β-Sitosterol |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
10 |
Linalool |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
11 |
Tannic Acid |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
12 |
Catechin |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
13 |
Epicatechin |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
14 |
Deacetyl-asperulosidic Acid (DAA) |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
15 |
Asperulo-Sidic Acid |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
16 |
Tigogenin |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
17 |
Oleanane |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
|
18 |
Ursane |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
Inactive |
ANTI MICROBIAL ACTIVITY
PREPARATION OF PROTEIN:
The protein target, obtained from the RCSB protein data bank with the PDB accession. Code 1ULK function as docking receptor. The active site of the receptor was cleared of all sound ligands and water molecules.
CRYSTAL STRUCTURE OF 1ULK
PDB DOI: https://doi.org/10.2210/pdb1ULK/pdb
Classification: SUGAR BINDING PROTEIN
Organism(s): Phytolacca americana
Mutation(s): No
Experimental Data Snapshot
BINDING AFFINITY
|
Sr. No |
Phytoconstituents |
Binding Affinity |
|
1 |
Ciproflaxacin |
-7.0023 |
|
2 |
Tannic Acid |
-10.3872 |
|
3 |
Rutin |
-8.1195 |
|
4 |
Beta Sitosterol |
-7.4976 |
|
5 |
Asperulosidic Acid |
-7.4150 |
|
6 |
Deacetyl Asperulosidic Acid (Daa) |
-7.3563 |
|
7 |
Urasane |
-7.0970 |
|
8 |
Ursolic Acid |
-7.0485 |
|
9 |
Oleonane |
-7.0445 |
|
10 |
Oleanolic Acid |
-6.9786 |
|
11 |
Tigogenin |
-6.7315 |
|
12 |
Epicatechin |
-6.7252 |
|
13 |
Quercetin |
-6.7019 |
|
14 |
Kaemoferol |
-6.6495 |
|
15 |
Catechin |
-6.6175 |
|
16 |
Scopoletin |
-6.2459 |
|
17 |
Linalool |
-6.2316 |
|
18 |
Caffeic Acid |
-6.1923 |
|
19 |
Gallic Acid |
-5.8714 |
MATRIALS AND METHOD
Processing of plant :
The collected plant has identified by Dr.V.Suresh kumar, Assistant Professor, Dept of Botany, Government Arts College, Tiruvannamalai (District), Tamilnadu, India. The plant was washed with tap water 3 times and sterilized by spraying with 70% alcohol.
The purified plant material was shade dried at room temperature to avoid chemical changes and frequently observed for any fungal contamination as the plant material rich in water content. When the plant material was dried entirely, it has subjected to prepare fine powder with help of mixer grinder. The fine material powder is collected and used for extraction of the crude drug in solvent by soxhlet and maceration extraction method.
DRIED FLOWERS
Soxhlet Extraction:
Soxhlet extraction is a method used to remove active compounds from plant material using heat and continuous solvent washing.
Maceration:
Maceration is a method of extracting compounds by soaking plant material in a solvent at room temperature for a long time.
Soxhlet ExtractionApparatus:
Procedure:
Advantages
Disadvantages
Maceration
Apparatus:
Procedure
Advantages
Disadvantages
Maceration process Soxhlet method
CONFIRMATION TESTS FOR CRUDE EXTRACTS
|
Sr. No |
CHEMICAL CONSTITUENTS |
TEST |
INFERENCE |
|
1. |
ALKALOIDS |
Dragendroff’s test |
+ve |
|
Mayer’s test |
+ve |
||
|
Wager’s test |
+ve |
||
|
Hager’s test |
+ve |
||
|
2. |
FLAVANOIDS |
Alkaline reagent test |
+ve |
|
Lead acetate test |
+ve |
||
|
3. |
SAPONINS |
Foam test |
-ve |
|
Emulsifiction test |
+ve |
||
|
4. |
TANNINS |
Ferric chloride test |
+ve |
|
Lead acetate test |
+ve |
||
|
5. |
GLYCOSIDES |
Keller-killianin test (for cardiac glycosides) |
-ve |
|
Borntagger’s test (for anthraquinone glycosides) |
+ve |
||
|
6. |
PHENOLS |
Ferric chloride test |
+ve |
|
Lead acetate test |
+ve |
METHOD
Plant extracts possess significant antimicrobial activity due to compounds like alkaloids, flavonoids, tannins and essential oil, Phenols offering natural alternative to synthetic drugs by inhibiting various bacteria and fungi, targeting pathogens like (BACILLUS, STAPHYLOCOCCUS).
Preparation of nutrient broth medium:
|
Sr. No |
Composition |
Standard Formula (1000ml) |
Working Formula (500ml) |
|
1 |
Beef Extract |
3 G |
1.5 G |
|
2 |
Peptone |
5 G |
2.5 G |
|
3 |
Sodium Chloride |
5 G |
2.5 G |
|
4 |
Agar |
15 G |
7.5 G |
|
5 |
Distilled Water |
1000ml |
500ml |
PROCEDURE:
COMMON METHODS:
BACILLUS
STANDARD SAMPLE
STAPHYLOCOCCUS
STANDARD SAMPLE
SERIAL DILUTION:
BLANK:
Add 1.5 g of Beef extract
↓
Add 2.5 g of Peptone
↓
Add 2.5 g of Sodium chloride
↓
Make up for 500ml with distilled water
↓
Autoclave the medium at 121?C for 15 minutes under psi pressure
↓
Cool to about 45-50 ?C
↓
Incubate at 37 ?C for 48 hours
↓
Measure absorbance at 254nm
CONTROL:
Add 10ml of nutrient broth
↓
Add 0.5ml of Micro-organism (Bacillus, Staphylococcus)
↓
Incubate at 37 ? C for 48hours
↓
Measure the absorbance at 254nm
STANDARD:
Add 10 ml of nutrient broth solution
↓
Add 0.5 ml of micro-organism (bacillus, staphylococcus)
↓
Add 0.5ml of 50 mcg Ciprofloxacin solution
↓
Incubate at 37 ?C for 48 hours
↓
Measure the absorbance at 254nm
TEST:
TEST FOR
100 mcg/ml, 200 mcg/ml, 300 mcg/ml, 400 mcg/ml, 500 mcg/ml, 600 mcg/ml, 700 mcg/ml, 800 mcg/ml, 900 mcg/ml, 1000 mcg/ml.
Add 10ml of nutrient broth solution
↓
Add0.5ml of micro-organism (Bacillus & Staphylococcus)
↓
Add 0.5ml of plant extract
↓
Incubate at 37 ?C for 48 hours
↓
Measure the absorbance at 254nm
RESULT
|
Sr. No |
Sample |
Conc (Mcg) |
Absorbance (Staphylo Coccus) |
Absorbance (Bacillus) |
% Inhibition (Staphylo Coccus) |
% Inhibition (Bacillus) |
|
Control |
2.1690 |
2.1690 |
0% |
0% |
||
|
Cipro- Floxacin |
50 |
0.4218 |
0.3042 |
80.55% |
85.97% |
|
|
1 |
Test |
100 |
1.4314 |
1.3812 |
34.00% |
36.32% |
|
2 |
Test |
200 |
0.8422 |
0.8599 |
61.17% |
60.35% |
|
3 |
Test |
300 |
0.8333 |
0.8448 |
61.58% |
61.05% |
|
4 |
Test |
400 |
0.7811 |
0.8183 |
63.98% |
62.27% |
|
5 |
Test |
500 |
0.7009 |
0.5114 |
67.68% |
76.42% |
|
6 |
Test |
600 |
0.6962 |
0.4227 |
67.90% |
80.51% |
|
7 |
Test |
700 |
0.6849 |
0.3826 |
68.42% |
82.36% |
|
8 |
Test |
800 |
0.4569 |
0.3809 |
78.93% |
82.43% |
|
9 |
Test |
900 |
0.4363 |
0.3042 |
79.88% |
85.97% |
|
10 |
Test |
1000 |
0.4212 |
0.1684 |
80.55% |
92.23% |
CALCULATION FORMULA:
% of inhibition =
(Absorbance of control - Absorbance of test) ×100
(Absorbance of control)
OBSERVATION
GRAPH
DISCUSSION:
1. Phytochemical Analysis
Preliminary phytochemical screening confirmed the presence of:
These compounds are known for their antimicrobial activity.
2. Antimicrobial Activity (Disc and Agar Well Diffusion Methods)
The antimicrobial activity was tested against:
Both disc diffusion and well diffusion methods showed measurable zones of inhibition. Larger zones were observed at higher concentrations of extract. Well diffusion method showed slightly higher inhibition compared to disc diffusion method. The extract exhibited stronger activity against Staphylococcus aureus than Bacillus subtilis.
3. Serial Dilution and Percentage Inhibition
Serial dilution method was used to determine Minimum Inhibitory Concentration (MIC).As concentration decreased, percentage inhibition also decreased. Highest concentration showed maximum microbial inhibition. MIC was determined as the lowest concentration showing no visible growth. Percentage inhibition was calculated using:
% of inhibition =
Absorbance of control - Absorbance of testAbsorbance of control ×100
Results indicated concentration-dependent antimicrobial activity.
4. Molecular Docking Analysis
Major phytocompounds from Morinda citrifolia were docked against microbial target proteins. Strong binding affinity was observed. Hydrogen bonding and hydrophobic interactions stabilized ligand-protein complexes. Docking scores supported the experimental antimicrobial results. This confirms that phytochemicals may inhibit microbial growth by interacting with essential proteins involved in cell wall synthesis and metabolic pathways.
CONCLUSION:
The present study demonstrates that Morinda citrifolia (Flowers) possesses significant antimicrobial activity against bacteria. The disc diffusion and well diffusion methods confirmed concentration-dependent inhibition, while serial dilution determined the MIC and percentage inhibition.
Phytochemical screening revealed the presence of bioactive compounds responsible for antimicrobial effects. Molecular docking analysis further supported these findings by showing strong interaction between plant phytoconstituents and microbial target proteins.
Therefore, Morinda citrifolia (Flowers) can be considered a promising natural antimicrobial agent and may be used in the development of alternative therapeutic drugs to combat microbial resistance.
REFERENCES
Dr. Suresh V, Dr. Senthilkumar S. K, Jayaseelan K, Arunadevi L, Blessy Bavina V, Chandramouli S, Charumathi. E, Deepa. R, Integrated In Silico and In Vitro Investigation of Antimicrobial Activity of Morinda citrifolia Ethanolic Extract, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 2, 4124-4141. https://doi.org/10.5281/zenodo.18776487
10.5281/zenodo.18776487